google_counter
background_img

University Hospital Cologne

location_on Cologne, Germany
7.5/10 from 82 Votes

CyberKnife Center ( 253165)

Simone Marnitz-Schulze

Prof. Dr. med.

Simone Marnitz-Schulze

Specialized in: oncology

Curriculum vitae keyboard_arrow_down

Prof. Simone Marnitz-Schulze  studied medicine in Charite, Berlin. She also received her doctorate in Charite, in the Department of Nuclear Medicine. The doctor began clinical training in the Department of Radiotherapy, Charite, Berlin (Prof. Budach). She completed the final stage of her internship in the Department of Radiation Therapy at the University Hospital Essen (Prof. Stuschke). Then Prof. Marnitz-Schulze decided on her specialization (treatment of gynecological oncological diseases). In 2007, she defended her doctoral dissertation and obtained venia legendi. In 2006, Dr. returned back to Charite and became the Leading Doctor and Deputy Head of the Department of Radiation Oncology and Radiation Therapy. In 2011, she was awarded the title of W2 Professor in radiation therapy (Charite).

Then the doctor headed the Department of Radiation Therapy and Radiation Oncology and was awarded W3 Professorship. Her focuses include  interdisciplinary treatment of gynecological tumors, as well as the evaluation and implementation of modern high-precision methods of radiation oncology with the aim of improving the results of treatment of oncological diseases and minimizing acute and late toxicity. Prof. Simone Marnitz-Schulze is a member of the interdisciplinary German Leading Group on the treatment of cervical cancer, as well as vulvar and vaginal cancer.

Since 01.10.2015 the professor has been the Chief Physician of the CyberKnife Center at the University Hospital Cologne.

The CyberKnife Center is equipped with the state-of-the-art radiation device, which can irradiate benign and malignant tumors of the head and body. The director of the center is Prof. Dr. Simone Marnitz-Schulze.  

The CyberKnife consists of a compact linear accelerator mounted on an automatic manipulator that directs numerous high energy beams of rays to a specific area of the body. Only the focus of all beams in the target leads to a destruction of the tumour tissue. The tumour spread can be determined by means of fluoroscopy and infrared sensors.

The CyberKnife Center provides the most effective treatment of small tumors and 1-5 cm lesions located deep in the skull or in the face, chest or abdominal cavity. Therefore, high resolution images (CT, MRI and sometimes PET), which should be available already when preparing for the therapy, play an extremely important role.

Brain and spinal cord:

  • Brain metastases (max. 3-4 metastases)
  • Acoustic neuromas
  • Meningneome
  • Pituitary adenomas
  • Glomus tumours
  • Arteriovenous malformations
  • Inoperable intraspinal tumors, etc.

Other organs:

  • Recurrences of ENT tumours
  • Peripheral, inoperable lung cancer
  • Central carcinoma without lymph node metastasis and bronchus infiltration
  • Lung metastases (max. 2-3 metastases)
  • Inoperable, well-defined pancreatic cancer
  • Liver metastases (max. 3 metastases)
  • Single or pre-irradiated spinal metastases and spinal tumours
  • Abdominal recurrent tumors and single lymph node metastases in the pelvis, etc.

Need Help?

Need Help?

Thank you!

We received your treatment application in the best Europe clinics. Our manager will contact you within the next 24 hours.